ClinicalTrials.gg
RecruitingNCT07507240EPISURUpdated Nov 16, 2026

The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Treatment

An interventional study of Remote monitoring training and Description of the standard care pathway in Epilepsy, sponsored by University Hospital, Toulouse. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Prevention

How we know

Updated Nov 16, 2026Now RecruitingSite recruiting status changed+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Epilepsy by University Hospital, Toulouse — 5 open to participants now, 6 under way, none of them phase 3. Epilepsy · University Hospital, Toulouse.

Started
2026
with 1 other
No phase
6 of 10
3 open now
Registered
9th of 10
by date

Among the 10 studies in Epilepsy by University Hospital, Toulouse, this one is one of 2 that started in 2026, is one of 6 with no phase, and was the 9th registered.

Epilepsy

1,850 studies on the registry are indexed under Epilepsy; 418 are open to participants now.

Browse Epilepsy studies →

Open to participants now

5 of the 10 studies in Epilepsy by University Hospital, Toulouse are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 284 Epilepsy studies recruiting now, 113 (40%) set no upper age limit and 148 (52%) stop at 75 or younger; 138 take children under 18; 54 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Epilepsy by University Hospital, Toulouse, or all of them as a file.
02

Study summary

Epilepsy is a chronic condition affecting approximately 600,000 people in France. Epilepsy treatment relies on antiepileptic drugs, the effectiveness of which depends on adherence to medication schedule, with missed doses increasing the risk of seizures. As with any chronic illness, epilepsy presents a significant challenge in terms of treatment adherence. Furthermore, despite good medication adherence, 30% of patients remain drug-resistant.

Therefore, the aim is to create a remote monitoring program, supported by a nurse, lasting six months after the introduction of a new antiepileptic drug, to support the patient until their next appointment with a neurologist. This system would optimize and secure the care pathway during treatment changes by improving the detection of side effects and/or a resurgence of seizures requiring medication adjustments.

03

Conditions studied

  • Epilepsy

Browse trials for

Keywords

  • epilepsy
  • remote monitoring
  • epilepsy treatment
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Confirmed diagnosis of epilepsy by a neurologist
  • Patient requiring the introduction of anti-epileptic medication as an add-on to their usual treatment or as a replacement for their current treatment(s)
  • Access to a reliable internet connection and a compatible device for remote monitoring (smartphone, tablet, computer)
  • Ability to understand and use remote communication technologies

Exclusion criteria

Exclusion Criteria:

  • Presence of concurrent neurological or psychiatric disorders affecting the ability to use remote monitoring.
  • Presence of a progressive neurological disease, including degenerative CNS disease, or a progressive tumor.
  • Change in treatment for pregnancy preparation.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Patients with remote monitoring

    Patients who will benefit from remote monitoring to support them in their changes to antiepileptic treatment

    Other: Remote monitoring training · Other: Therapeutic support with a nurse · Diagnostic Test: Questionnaires for the two groups · Other: Satisfaction questionnaire for the group with remote monitoring

  • Active comparator
    Patients without remote monitoring

    Patients who will receive standard care without remote monitoring as part of a change in anti-epileptic treatment

    Other: Description of the standard care pathway · Diagnostic Test: Questionnaires for the two groups

Interventions

  • OtherRemote monitoring training

    Training in the care pathway via remote monitoring software

  • OtherDescription of the standard care pathway

    Description of the standard care pathway with the nurse

  • OtherTherapeutic support with a nurse

    Therapeutic support with a nurse who ensures the patient's adherence to remote monitoring at 1 month and 3 months

  • Diagnostic testQuestionnaires for the two groups

    Quality of life questionnaires at baseline and at 6 months

  • OtherSatisfaction questionnaire for the group with remote monitoring

    Satisfaction questionnaire for the group with remote monitoring at 6 months

06

What researchers measure

Primary outcomes

  1. Describe the evolution of therapeutic adherence

    Measurement of the Mascard scale score in 2 groups of patients benefiting or not from the new care and support pathway.

    Time frame: 6 months after the inclusion

Secondary outcomes

  1. Evolution of Quality of Life between baseline and 6 months

    Evolution of the score on the QOLIE 31 quality of life scale between the beginning and the end of the course between 2 groups

    Time frame: 6 months after the inclusion

  2. Description of the care pathway between baseline and 6 months

    Description of the number of consultations in both groups between baseline and 6 months

    Time frame: 6 months after the inclusion

  3. Description of patient satisfaction with their medical care

    Patient satisfaction score on epilepsy care questionnaire

    Time frame: 6 months after the inclusion

  4. Evaluation of patient acceptability of remote monitoring

    Patient satisfaction questionnaire score regarding the use of the digital tool for the group of patients who received care via remote monitoring

    Time frame: 6 months after the inclusion

  5. Evaluation of satisfaction with the use of remote monitoring by the healthcare team

    Score on the satisfaction questionnaire regarding the use of remote monitoring by the care team,

    Time frame: 6 months after the inclusion

07

Study locations

1 of 1 sites recruiting
  • Cerebral electrophysiology, epilepsy and sleep, Purpan Hospital, Place du Docteur Baylac
    Toulouse, Non 31059, France
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Apr 2028, 18 months after the start.

Of 339 non-industry interventional studies with no phase under Epilepsy, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 77. This study's planned 18 months is below that.

Counting every sponsor, half of 360 studies reached it within 42 months; a quarter within 19 and three quarters within 77.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: start May 2026 → Oct 2026, primary completion Nov 2027 → Apr 2028 and completion May 2028 → Oct 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 27, 2026
First posted
Apr 2, 2026
StartActual
Oct 29, 2026was May 2026
Primary completionEst.
Apr 29, 2028was Nov 2027
CompletionEst.
Oct 29, 2028was May 2028
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 16, 2026
Sites
Cerebral electrophysiology, epilepsy and sleep, Purpan Hospital, Place du Docteur Baylac is now Recruiting
Nov 16, 2026
Start date
May 1, 2026→Oct 29, 2026 (actual)
Nov 16, 2026
Primary completion
Nov 1, 2027→Apr 29, 2028
Nov 16, 2026
Study completion
May 1, 2028→Oct 29, 2028
Nov 16, 2026
Title
The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Treatment: a Pilot Study
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Not yet recruiting→Recruiting
    Cerebral electrophysiology, epilepsy and sleep, Purpan Hospital, Place du Docteur Baylac is now Recruiting
    Start date May 1, 2026→Oct 29, 2026 (now actual)
    Primary completion Nov 1, 2027→Apr 29, 2028
    Study completion May 1, 2028→Oct 29, 2028
    Title The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Treatment: a Pilot Study
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07507240
Responsible party
Sponsor
First posted
Apr 2, 2026
Start date
Oct 29, 2026
Primary completion
Apr 29, 2028 (estimated)
Completion
Oct 29, 2028 (estimated)
Last update
Nov 16, 2026

Study contacts

Marie DENUELLE, MD
Contact
denuelle.m@chu-toulouse.fr
05 61 77 94 24 ext. +33

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion